dc.contributor.author | Mohammadian, T | |
dc.contributor.author | Bonyadi, M | |
dc.contributor.author | Nabat, E | |
dc.contributor.author | Rafeey, M | |
dc.date.accessioned | 2018-08-26T08:36:12Z | |
dc.date.available | 2018-08-26T08:36:12Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52721 | |
dc.description.abstract | Background. Henoch-Sch?nlein purpura (HSP) is a multisystem, small vessel, leucocytoclastic vasculitis. It is predominantly a childhood vasculitis, rarely reported in adults. Studies have shown that several different genetic factors such as genes involved in inflammatory system and renin-angiotensin system (RAS) are important in the pathogenesis of Henoch-Sch?nlein purpura. Objectives. The purpose of this study was to evaluate the independent effect of 3 gene polymorphisms including CCL2-2518 C/T, VEGF-634G/C and ACE(I/D) with HSP disease and their possible joint interactions in developing the disease. Material and methods. In this case-control study 47 HSP cases and 74 unrelated healthy controls were enrolled for evaluation. All individuals were genotyped for CCL2-2518C/T, VEGF-634G/C and ACE(I/D) gene polymorphisms. The possible association of these polymorphisms with susceptibility to develop HSP disease independently and in different joint combinations was evaluated. Results. The frequencies of TT genotype and T allele of CCL2-2518C/T gene polymorphism and CC genotype and C allele of VEGF-634G/C gene polymorphism were significantly high in HSP children (p-values = 0.005 and = 0.007 respectively). Interestingly, studying the joint interaction of these 2 genotypes (CC genotype of VEGF G-634C and TT genotype of CCL2 C-2518T) in this cohort showed a more significant effect in the development of the disease (p < 0.000, OR = 6.009). The frequency of TT genotype of CCL2 gene when combined with II genotype of ACE gene in HSP children was significantly higher (p < 0.000, OR = 4.213). Conclusions. The results of this pilot study provide evidence of the possible gene-gene interaction effects of CCL2, VEGF and ACE genes in developing HSP disease. é 2017 by Wroclaw Medical University. | |
dc.language.iso | English | |
dc.relation.ispartof | Advances in Clinical and Experimental Medicine | |
dc.subject | dipeptidyl carboxypeptidase | |
dc.subject | genomic DNA | |
dc.subject | monocyte chemotactic protein 1 | |
dc.subject | restriction endonuclease | |
dc.subject | vasculotropin | |
dc.subject | CCL2 protein, human | |
dc.subject | dipeptidyl carboxypeptidase | |
dc.subject | monocyte chemotactic protein 1 | |
dc.subject | vasculotropin A | |
dc.subject | VEGFA protein, human | |
dc.subject | anaphylactoid purpura | |
dc.subject | Article | |
dc.subject | child | |
dc.subject | clinical article | |
dc.subject | clinical evaluation | |
dc.subject | cohort analysis | |
dc.subject | controlled study | |
dc.subject | disease association | |
dc.subject | DNA polymorphism | |
dc.subject | female | |
dc.subject | gene frequency | |
dc.subject | gene interaction | |
dc.subject | gene locus | |
dc.subject | genetic analysis | |
dc.subject | genetic association | |
dc.subject | genetic susceptibility | |
dc.subject | genotype | |
dc.subject | heredity | |
dc.subject | human | |
dc.subject | male | |
dc.subject | school child | |
dc.subject | anaphylactoid purpura | |
dc.subject | case control study | |
dc.subject | epistasis | |
dc.subject | genetic predisposition | |
dc.subject | genetics | |
dc.subject | single nucleotide polymorphism | |
dc.subject | Case-Control Studies | |
dc.subject | Chemokine CCL2 | |
dc.subject | Child | |
dc.subject | Epistasis, Genetic | |
dc.subject | Female | |
dc.subject | Genetic Predisposition to Disease | |
dc.subject | Genotype | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Peptidyl-Dipeptidase A | |
dc.subject | Polymorphism, Single Nucleotide | |
dc.subject | Purpura, Schoenlein-Henoch | |
dc.subject | Vascular Endothelial Growth Factor A | |
dc.title | Association of ACE, VEGF and CCL2 gene polymorphisms with Henoch-Sch?nlein purpura and an evaluation of the possible interaction effects of these loci in HSP patients | |
dc.type | Article | |
dc.citation.volume | 26 | |
dc.citation.issue | 4 | |
dc.citation.spage | 661 | |
dc.citation.epage | 664 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.17219/acem/62896 | |